Drug
Rdd TO Palynziq
Rdd TO Palynziq: highest development phase Post-Market, developed by BioMarin Pharmaceutical. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- BioMarin Pharmaceutical
Trials
| Drug | Phase | Indication |
|---|---|---|
| RDD to Palynziq NCT06780332 | Post-Market | Phenylketonuria |
Latest
No recent events.
Follow Rdd TO Palynziq on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.